Cases & Deals

Celgene defends its patent covering pomalidomide and dexamethasone in EP opposition proceedings

Clients Celgene Corporation

Jones Day represents Celgene Corporation in opposition proceedings initiated by six generic companies regarding a Celgene European patent covering pomalidomide and dexamethasone.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.